Vasodilator agents protect against indinavir nephrotoxicity

Detalhes bibliográficos
Autor(a) principal: Araujo, Magali de [UNIFESP]
Data de Publicação: 2003
Outros Autores: Seguro, Antonio Carlos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/11600/42611
https://www.intmedpress.com/journals/avt/abstract.cfm?id=1046&pid=88
Resumo: Indinavir (IDV) is a protease inhibitor widely used in AIDS treatment. A sustained elevation of creatinine was identified in IDV-treated patients. We have previously demonstrated that IDV causes renal vasoconstriction in rats. The objective of this study was to investigate the mechanism of IDV-induced vasoconstriction and the effect that the vasodilator agents L-arginine (LA), nifedipine (NF), as well as magnesium supplementation (Mg), have on IDV-induced nephrotoxicity. Male Wistar rats were kept on fast overnight and given free access to water. IDV (80 mg/kg BW) and NF (3 mg/kg BW) were given by gavage for 15 days. LA (1.5%) and MgCl(2)center dot 6H(2)O (11%) were added to drinking water. Six groups were studied: Control (n=6): normal rats treated with vehicle, a 0.05 M citric acid solution; IDV (n=7): IDV-treated rats; IDV+LA (n=6): IDV- and LA-treated rats; IDV+NF (n=7): IDV- and NF-treated rats; IDV+Mg (n=7): IDV- and MgCl2-treated rats; IDV+Mg+L-NAME (n=9): IDV- and MgCl2-treated rats, supplemented with L-NAME (2.5 mg/l in drinking water). Clearance studies and evaluations of urinary nitrite (NO2) excretion were performed on day 16. No changes in blood pressure were observed. NO2 excretion decreased in IDV-treated rats. LA and NF protected against IDV effects, improving GFR (IDV+LA, 1.95 +/-0.10; IDV+NF, 1.94 +/-0.07 vs IDV, 1.15 +/-0.07 ml/min, P<0.001) and RBF (IDV+LA, 7.83 +/-0.09; IDV+NF, 7.63 +/-0.14 vs IDV, 6.17 +/-0.25 ml/min, P<0.001). These results suggest that IDV-induced vasoconstriction is mediated by NO and Ca2+ channels. Magnesium also ameliorated GFR and RBF in IDV-treated rats (GFR IDV+Mg, 1.77 +/-0.08 ml/min, P<0.001; RBF IDV+Mg, 7.35 +/-0.158 ml/min, P<0.001). Magnesium protection is not NO-mediated since it was not blocked by L-NAME. In conclusion, LA, NF and Mg protect against IDV-induced nephrotoxicity in rats. This study may have potential clinical implications for prevention of IDV-induced nephrotoxicity.
id UFSP_5940f1c5bc566fd809d640800f2c7503
oai_identifier_str oai:repositorio.unifesp.br:11600/42611
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Araujo, Magali de [UNIFESP]Seguro, Antonio CarlosUniversidade de São Paulo (USP)Universidade Federal de São Paulo (UNIFESP)2018-06-15T13:50:16Z2018-06-15T13:50:16Z2003-08-01Antiviral Therapy. London: Int Medical Press Ltd, v. 8, n. 4, p. 295-299, 2003.1359-6535http://repositorio.unifesp.br/11600/42611https://www.intmedpress.com/journals/avt/abstract.cfm?id=1046&pid=88WOS:000231266500005Indinavir (IDV) is a protease inhibitor widely used in AIDS treatment. A sustained elevation of creatinine was identified in IDV-treated patients. We have previously demonstrated that IDV causes renal vasoconstriction in rats. The objective of this study was to investigate the mechanism of IDV-induced vasoconstriction and the effect that the vasodilator agents L-arginine (LA), nifedipine (NF), as well as magnesium supplementation (Mg), have on IDV-induced nephrotoxicity. Male Wistar rats were kept on fast overnight and given free access to water. IDV (80 mg/kg BW) and NF (3 mg/kg BW) were given by gavage for 15 days. LA (1.5%) and MgCl(2)center dot 6H(2)O (11%) were added to drinking water. Six groups were studied: Control (n=6): normal rats treated with vehicle, a 0.05 M citric acid solution; IDV (n=7): IDV-treated rats; IDV+LA (n=6): IDV- and LA-treated rats; IDV+NF (n=7): IDV- and NF-treated rats; IDV+Mg (n=7): IDV- and MgCl2-treated rats; IDV+Mg+L-NAME (n=9): IDV- and MgCl2-treated rats, supplemented with L-NAME (2.5 mg/l in drinking water). Clearance studies and evaluations of urinary nitrite (NO2) excretion were performed on day 16. No changes in blood pressure were observed. NO2 excretion decreased in IDV-treated rats. LA and NF protected against IDV effects, improving GFR (IDV+LA, 1.95 +/-0.10; IDV+NF, 1.94 +/-0.07 vs IDV, 1.15 +/-0.07 ml/min, P<0.001) and RBF (IDV+LA, 7.83 +/-0.09; IDV+NF, 7.63 +/-0.14 vs IDV, 6.17 +/-0.25 ml/min, P<0.001). These results suggest that IDV-induced vasoconstriction is mediated by NO and Ca2+ channels. Magnesium also ameliorated GFR and RBF in IDV-treated rats (GFR IDV+Mg, 1.77 +/-0.08 ml/min, P<0.001; RBF IDV+Mg, 7.35 +/-0.158 ml/min, P<0.001). Magnesium protection is not NO-mediated since it was not blocked by L-NAME. In conclusion, LA, NF and Mg protect against IDV-induced nephrotoxicity in rats. This study may have potential clinical implications for prevention of IDV-induced nephrotoxicity.USP, Fac Med, Disciplina Nefrol, Lab Pesquisa Basica LIM12, BR-09500900 Sao Paulo, BrazilUniv Fed Sao Paulo, Sao Paulo, BrazilUniv Fed Sao Paulo, Sao Paulo, BrazilWeb of Science295-299engInt Medical Press LtdAntiviral TherapyVasodilator agents protect against indinavir nephrotoxicityinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP11600/426112021-10-05 22:00:45.602metadata only accessoai:repositorio.unifesp.br:11600/42611Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652021-10-06T01:00:45Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Vasodilator agents protect against indinavir nephrotoxicity
title Vasodilator agents protect against indinavir nephrotoxicity
spellingShingle Vasodilator agents protect against indinavir nephrotoxicity
Araujo, Magali de [UNIFESP]
title_short Vasodilator agents protect against indinavir nephrotoxicity
title_full Vasodilator agents protect against indinavir nephrotoxicity
title_fullStr Vasodilator agents protect against indinavir nephrotoxicity
title_full_unstemmed Vasodilator agents protect against indinavir nephrotoxicity
title_sort Vasodilator agents protect against indinavir nephrotoxicity
author Araujo, Magali de [UNIFESP]
author_facet Araujo, Magali de [UNIFESP]
Seguro, Antonio Carlos
author_role author
author2 Seguro, Antonio Carlos
author2_role author
dc.contributor.institution.none.fl_str_mv Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Araujo, Magali de [UNIFESP]
Seguro, Antonio Carlos
description Indinavir (IDV) is a protease inhibitor widely used in AIDS treatment. A sustained elevation of creatinine was identified in IDV-treated patients. We have previously demonstrated that IDV causes renal vasoconstriction in rats. The objective of this study was to investigate the mechanism of IDV-induced vasoconstriction and the effect that the vasodilator agents L-arginine (LA), nifedipine (NF), as well as magnesium supplementation (Mg), have on IDV-induced nephrotoxicity. Male Wistar rats were kept on fast overnight and given free access to water. IDV (80 mg/kg BW) and NF (3 mg/kg BW) were given by gavage for 15 days. LA (1.5%) and MgCl(2)center dot 6H(2)O (11%) were added to drinking water. Six groups were studied: Control (n=6): normal rats treated with vehicle, a 0.05 M citric acid solution; IDV (n=7): IDV-treated rats; IDV+LA (n=6): IDV- and LA-treated rats; IDV+NF (n=7): IDV- and NF-treated rats; IDV+Mg (n=7): IDV- and MgCl2-treated rats; IDV+Mg+L-NAME (n=9): IDV- and MgCl2-treated rats, supplemented with L-NAME (2.5 mg/l in drinking water). Clearance studies and evaluations of urinary nitrite (NO2) excretion were performed on day 16. No changes in blood pressure were observed. NO2 excretion decreased in IDV-treated rats. LA and NF protected against IDV effects, improving GFR (IDV+LA, 1.95 +/-0.10; IDV+NF, 1.94 +/-0.07 vs IDV, 1.15 +/-0.07 ml/min, P<0.001) and RBF (IDV+LA, 7.83 +/-0.09; IDV+NF, 7.63 +/-0.14 vs IDV, 6.17 +/-0.25 ml/min, P<0.001). These results suggest that IDV-induced vasoconstriction is mediated by NO and Ca2+ channels. Magnesium also ameliorated GFR and RBF in IDV-treated rats (GFR IDV+Mg, 1.77 +/-0.08 ml/min, P<0.001; RBF IDV+Mg, 7.35 +/-0.158 ml/min, P<0.001). Magnesium protection is not NO-mediated since it was not blocked by L-NAME. In conclusion, LA, NF and Mg protect against IDV-induced nephrotoxicity in rats. This study may have potential clinical implications for prevention of IDV-induced nephrotoxicity.
publishDate 2003
dc.date.issued.fl_str_mv 2003-08-01
dc.date.accessioned.fl_str_mv 2018-06-15T13:50:16Z
dc.date.available.fl_str_mv 2018-06-15T13:50:16Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Antiviral Therapy. London: Int Medical Press Ltd, v. 8, n. 4, p. 295-299, 2003.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/11600/42611
https://www.intmedpress.com/journals/avt/abstract.cfm?id=1046&pid=88
dc.identifier.issn.none.fl_str_mv 1359-6535
dc.identifier.wos.none.fl_str_mv WOS:000231266500005
identifier_str_mv Antiviral Therapy. London: Int Medical Press Ltd, v. 8, n. 4, p. 295-299, 2003.
1359-6535
WOS:000231266500005
url http://repositorio.unifesp.br/11600/42611
https://www.intmedpress.com/journals/avt/abstract.cfm?id=1046&pid=88
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Antiviral Therapy
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 295-299
dc.publisher.none.fl_str_mv Int Medical Press Ltd
publisher.none.fl_str_mv Int Medical Press Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764166165954560